Cancer Genetics Inc (CGIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
28 Pages - GLDATA62672
$250.00

Summary

Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI’s clinical services include expand DX, test menu, complete program, and summation report. The company offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and for biotech and biopharma customers engaged in clinical trials. It works in research collaboration with cancer centers to develop and validate proprietary tests. CGI is headquartered in Rutherford, New Jersey, the US.

Cancer Genetics Inc (CGIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cancer Genetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cancer Genetics Enters into Agreement with Lantern Pharma 11
Cancer Genetics Enters into Agreement with Biotech and Pharma Companies 11
Cancer Genetics Enters into Agreement with BeiGene 12
Cancer Genetics Enters into Co-Marketing Agreement with Bio Analytical Research 13
Cancer Genetics Partners with H3 Biomedicine 13
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 14
Mayo Clinic Forms Joint Venture With Cancer Genetics 15
Cancer Genetics Enters Into Agreement With Gilead Sciences To Provide Clinical Trial Services 16
Gentris Enters Into Co-Development With Shanghai Institutes of Preventive Medicine 17
Aptiv Solutions Enters Into Joint Venture Agreement With Cancer Genetics 18
Equity Offering 18
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 18
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 20
Cancer Genetics Raises USD12 Million in Public Offering of Shares 21
Acquisition 22
Cancer Genetics Acquires Gentris for USD4.75 Million 22
Cancer Genetics Inc - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cancer Genetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cancer Genetics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Enters into Agreement with Lantern Pharma 11
Cancer Genetics Enters into Agreement with Biotech and Pharma Companies 11
Cancer Genetics Enters into Agreement with BeiGene 12
Cancer Genetics Enters into Co-Marketing Agreement with Bio Analytical Research 13
Cancer Genetics Partners with H3 Biomedicine 13
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 14
Mayo Clinic Forms Joint Venture With Cancer Genetics 15
Cancer Genetics Enters Into Agreement With Gilead Sciences To Provide Clinical Trial Services 16
Gentris Enters Into Co-Development With Shanghai Institutes of Preventive Medicine 17
Aptiv Solutions Enters Into Joint Venture Agreement With Cancer Genetics 18
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 18
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 20
Cancer Genetics Raises USD12 Million in Public Offering of Shares 21
Cancer Genetics Acquires Gentris for USD4.75 Million 22
Cancer Genetics Inc, Key Competitors 24
Cancer Genetics Inc, Key Employees 25
Cancer Genetics Inc, Other Locations 27
Cancer Genetics Inc, Subsidiaries 27

List of Figures
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cancer Genetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838